Commission Implementing Regulation (EU) 2022/1218 of 14 July 2022 amending certain Annexes to Implementing Regulation (EU) 2021/620 as regards the approval of the disease-free status of certain Member States or zones thereof as regards certain listed diseases and the approval of eradication programmes for certain listed diseases (Text with EEA relevance)
Commission Implementing Regulation (EU) 2022/1218of 14 July 2022amending certain Annexes to Implementing Regulation (EU) 2021/620 as regards the approval of the disease-free status of certain Member States or zones thereof as regards certain listed diseases and the approval of eradication programmes for certain listed diseases(Text with EEA relevance) THE EUROPEAN COMMISSION,Having regard to the Treaty on the Functioning of the European Union,Having regard to Regulation (EU) 2016/429 of the European Parliament and of the Council of 9 March 2016 on transmissible animal diseases and amending and repealing certain acts in the area of animal health ("Animal Health Law")OJ L 84, 31.3.2016, p. 1., and in particular Articles 31(3) and 36(4) thereof,Whereas:(1)Regulation (EU) 2016/429 lays down disease-specific rules for the diseases listed in accordance with Article 5(1) thereof and lays down how those rules are to be applied to different categories of listed diseases. Regulation (EU) 2016/429 provides for the Member States to establish compulsory eradication programmes for the listed diseases referred to in Article 9(1), point (b), thereof, and for optional eradication programmes for listed diseases referred to in Article 9(1), point (c), thereof, and for the approval of such programmes by the Commission. That Regulation also provides for the approval or withdrawal by the Commission of the disease-free status of Member States or zones or compartments thereof with regard to certain listed diseases referred to in Article 9(1), points (b) and (c), thereof.(2)Commission Delegated Regulation (EU) 2020/689Commission Delegated Regulation (EU) 2020/689 of 17 December 2019 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council as regards rules for surveillance, eradication programmes, and disease-free status for certain listed and emerging diseases (OJ L 174, 3.6.2020, p. 211). supplements Regulation (EU) 2016/429 and lays down the criteria for granting, maintaining, suspending and withdrawing disease-free status for Member States or zones or compartments thereof, and the requirements for the approval of compulsory or optional eradication programmes for Member States or zones or compartments thereof.(3)Commission Implementing Regulation (EU) 2021/620Commission Implementing Regulation (EU) 2021/620 of 15 April 2021 laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the approval of the disease-free and non-vaccination status of certain Member States or zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for those listed diseases (OJ L 131, 16.4.2021, p. 78). lays down implementing rules for the listed diseases referred to in Article 9(1), points (a), (b) and (c), of Regulation (EU) 2016/429 of animals, as regards the disease-free and non-vaccination status of certain Member States or zones or compartments thereof, and the approval of eradication programmes for those listed diseases. More particularly, it lists in the Annexes thereto, the Member States or zones or compartments thereof with disease-free status and it also lists the existing approved eradication programmes. The changing epidemiological situation of certain diseases makes it necessary to list new disease-free Member States or zones thereof and to approve certain eradication programmes submitted to the Commission.(4)For infection with Brucella abortus, B. melitensis and B. suis, infection with Mycobacterium tuberculosis complex (Mycobacterium bovis, M. caprae and M. tuberculosis) (MTBC), enzootic bovine leukosis (EBL), infection with bovine viral diarrhoea (BVD), and infection with bluetongue virus (serotypes 1-24) (BTV), several Member States have recently applied to the Commission to have disease-free status or eradication programmes approved for the whole or for part of their territory.(5)For infection with Brucella abortus, B. melitensis and B. suis in bovine animals, Italy has submitted to the Commission information demonstrating that the conditions for the recognition of disease-free status laid down in Delegated Regulation (EU) 2020/689 are fulfilled in the Province of Vibo Valentia in the Region of Calabria and in the Province of Teramo in the Region of Abruzzo. Therefore, those zones should be listed as free from infection with Brucella abortus, B. melitensis and B. suis in bovine animals in Part I, Chapter 1, of Annex I to Implementing Regulation (EU) 2021/620.(6)For infection with Brucella abortus, B. melitensis and B. suis in ovine and caprine animals, Italy has submitted to the Commission information demonstrating that the conditions for the recognition of disease-free status laid down in Delegated Regulation (EU) 2020/689 are fulfilled in the Province of Lecce in the Region of Puglia. Therefore, that zone should be listed as free from infection with Brucella abortus, B. melitensis and B. suis in ovine and caprine animals in Part I, Chapter 2, of Annex I to Implementing Regulation (EU) 2021/620.(7)For infection with MTBC, Italy has submitted to the Commission information demonstrating that the conditions for recognition of disease-free status from infection with MTBC laid down in Delegated Regulation (EU) 2020/689 are fulfilled in the Provinces of Aquila, Chieti and Teramo in the Region of Abruzzo, in the Province of Latina in the Region of Lazio, in the Provinces of Bari and Taranto in the Region of Puglia and in the Province of Nuoro in the Region of Sardinia. Therefore, those zones should be listed as free from infection with MTBC in Part I of Annex II to Implementing Regulation (EU) 2021/620.(8)For infection with EBL, Croatia has submitted to the Commission an application to have an eradication programme approved for its territory. Following the assessment by the Commission, that application has been shown to comply with the criteria laid down in Chapter 2 of Part II of Delegated Regulation (EU) 2020/689 for approval of eradication programmes for EBL. Therefore, this Member State should be listed accordingly in Part II of Annex IV to Implementing Regulation (EU) 2021/620, as having an approved eradication programme for EBL.(9)For infection with BVD, Denmark and Germany have submitted to the Commission information demonstrating that the conditions for recognition of the disease-free status from BVD laid down in Delegated Regulation (EU) 2020/689 are fulfilled on the whole territory of Denmark and in Landkreis Ravensburg, Erding, Weilheim-Schongau, Oberallgäu and Fulda in Germany, respectively. Therefore, that Member State and those zones should be listed accordingly in Part I of Annex VII to Implementing Regulation (EU) 2021/620, as having disease-free status from BVD.(10)For infection with BVD, Ireland has submitted to the Commission an application to have an eradication programme approved for its territory. Following the assessment by the Commission, that application has been shown to comply with the criteria laid down in Part II, Chapter 2, of Delegated Regulation (EU) 2020/689 for approval of eradication programmes for BVD. Therefore, this Member State should be listed accordingly in Part II of Annex VII to Implementing Regulation (EU) 2021/620, as having an approved eradication programme for BVD.(11)As regards infection with BTV, Germany has submitted to the Commission information demonstrating that the conditions for recognition of disease-free status from BTV are fulfilled for the whole territory of Baden-Württemberg, Hessen and Nordrhein-Westfalen. Following the assessment by the Commission, those applications have been shown to comply with the criteria laid down in Part II, Chapter 2, of Delegated Regulation (EU) 2020/689 for the granting of disease-free status for BTV. Therefore, those zones should be listed in Part I of Annex VIII to Implementing Regulation (EU) 2021/620, as having disease-free status from BTV.(12)Annexes I, II, IV, VII and VIII to Implementing Regulation (EU) 2021/620 should therefore be amended accordingly.(13)The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,HAS ADOPTED THIS REGULATION:
Article 1Annexes I, II, IV, VII and VIII to Implementing Regulation (EU) 2021/620 are amended in accordance with the Annex to this Regulation.
Article 2This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.Done at Brussels, 14 July 2022.For the CommissionThe PresidentUrsula von der LeyenANNEXAnnexes I, II, IV, VII and VIII to Implementing Regulation (EU) 2021/620 are amended as follows:(1)Annex I is amended as follows:(a)Part I is amended as follows:(i)in Chapter 1, the entry for Italy is replaced by the following:
Member StateTerritory
"ItalyRegione Abruzzo: Provincia di Pescara, TeramoRegione Calabria: Provincia di Vibo ValentiaRegione Campania: Province di Avellino, Benevento, NapoliRegione Emilia-RomagnaRegione Friuli Venezia GiuliaRegione LazioRegione LiguriaRegione LombardiaRegione MarcheRegione Molise: Provincia di CampobassoRegione PiemonteRegione Puglia: Province di Bari, Barletta-Andria-Trani, Brindisi, LecceRegione SardegnaRegione ToscanaRegione Trentino – Alto AdigeRegione UmbriaRegione Valle d’AostaRegione Veneto"
(ii)Chapter 2 is replaced by the following:"CHAPTER 2Member States or zones thereof with disease-free status from infection with Brucella abortus, B. melitensis and B. suis in ovine and caprine animal populations
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland."
Member StateTerritory
BelgiumWhole territory
CzechiaWhole territory
DenmarkWhole territory
GermanyWhole territory
EstoniaWhole territory
IrelandWhole territory
SpainWhole territory
FranceRégion Auvergne et Rhône-AlpesRégion Bourgogne-Franche-ComtéRégion BretagneRégion Centre-Val de LoireRégion CorseRégion Grande EstRégion Hauts-de-FranceRégion Ile-de-FranceRégion NormandieRégion Nouvelle-AquitaineRégion OccitanieRégion Pays de la LoireRégion Provence-Alpes-Côte d’Azur
ItalyRegione AbruzzoRegione Calabria: Province di Catanzaro, CosenzaRegione Campania: Provincia di BeneventoRegione Emilia-RomagnaRegione Friuli Venezia GiuliaRegione LazioRegione LiguriaRegione LombardiaRegione MarcheRegione MoliseRegione PiemonteRegione Puglia: Province di Bari, Barletta-Andria-Trani, Brindisi, Lecce, TarantoRegione SardegnaRegione ToscanaRegione Trentino – Alto AdigeRegione UmbriaRegione Valle d’AostaRegione Veneto
CyprusWhole territory
LatviaWhole territory
LithuaniaWhole territory
LuxembourgWhole territory
HungaryWhole territory
NetherlandsWhole territory
AustriaWhole territory
PolandWhole territory
PortugalRegião Autónoma dos Açores
RomaniaWhole territory
SloveniaWhole territory
SlovakiaWhole territory
FinlandWhole territory
SwedenWhole territory
United Kingdom (Northern Ireland)Northern Ireland
----------------------
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland."(b)Part II is amended as follows:(i)in Chapter 1, the entry for Italy is replaced by the following:
Member StateTerritory
"ItalyRegione Abruzzo: Provincia dell’Aquila, di ChietiRegione BasilicataRegione Calabria: Provincia di Catanzaro, Cosenza, Crotone, Reggio CalabriaRegione Campania: Provincia di Caserta, SalernoRegione Molise: Provincia di IserniaRegione Puglia: Provincia di Foggia, TarantoRegione Sicilia"
(ii)in Chapter 2, the entry for Italy is replaced by the following:
Member StateTerritory
"ItalyRegione BasilicataRegione Calabria: Provincia di Crotone, Reggio Calabria, Vibo ValentiaRegione Campania: Provincia di Caserta, Salerno, Avellino, NapoliRegione Puglia: Provincia di FoggiaRegione Sicilia"
(2)Annex II is amended as follows:(a)Part I is replaced by the following:"PART IMember States or zones thereof with disease-free status from infection with MTBC
Member StateTerritory
BelgiumWhole territory
CzechiaWhole territory
DenmarkWhole territory
GermanyWhole territory
EstoniaWhole territory
SpainComunidad Autónoma de CanariasComunidad Autónoma de GaliciaComunidad Autónoma del País VascoComunidad Autónoma del Principado de Asturias
FranceWhole territory
ItalyRegione AbruzzoRegione Basilicata: Provincia di MateraRegione Emilia-RomagnaRegione Friuli Venezia GiuliaRegione Lazio: Provincia di Frosinone, Latina, Rieti, ViterboRegione LiguriaRegione LombardiaRegione Marche: Provincia di Ancona, Ascoli Piceno, Fermo, Pesaro-UrbinoRegione MoliseRegione PiemonteRegione Puglia: Provincia di Bari, TarantoRegione Sardegna: Citta metropolitana di Cagliari, Provincia di Nuoro, Oristano, Sud SardegnaRegione ToscanaRegione Trentino – Alto AdigeRegione UmbriaRegione Valle d’AostaRegione Veneto
LatviaWhole territory
LithuaniaWhole territory
LuxembourgWhole territory
HungaryWhole territory
NetherlandsWhole territory
AustriaWhole territory
PolandWhole territory
PortugalRegião Algarve: all distritosRegião Autónoma dos Açores except Ilha de São Miguel
SloveniaWhole territory
SlovakiaWhole territory
FinlandWhole territory
SwedenWhole territory"
(b)Part II is replaced by the following:"PART IIMember States or zones thereof with an approved eradication programme for infection with MTBC
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland."
Member StateTerritory
BulgariaWhole territory
CroatiaWhole territory
CyprusWhole territory
GreeceWhole territory
IrelandWhole territory
ItalyRegione Basilicata: Provincia di PotenzaRegione CalabriaRegione CampaniaRegione Lazio: Provincia di RomaRegione Marche: Provincia di MacerataRegione Puglia: Provincia di Barletta-Adria-Trani, Brindisi, Foggia, LecceRegione Sardegna: Provincia di SassariRegione Sicilia
MaltaWhole territory
PortugalRegião Autónoma dos Açores: Ilha de São MiguelRegião Autónoma da MadeiraDistritos Aveiro, Beja, Braga, Bragança, Castelo Branco, Coimbra, Evora, Guarda, Leiria, Lisboa, Portalegre, Porto, Santarem, Setubal, Viana do Castelo, Vila Real, Viseu
RomaniaWhole territory
SpainComunidad Autónoma de AndalucíaComunidad Autónoma de AragónComunidad Autónoma de Islas BalearesComunidad Autónoma de CantabriaComunidad Autónoma de Castilla-La ManchaComunidad Autónoma de Castilla y LeónComunidad Autónoma de CataluñaComunidad Autónoma de ExtremaduraComunidad Autónoma de La RiojaComunidad Autónoma de MadridComunidad Autónoma de MurciaComunidad Autónoma de Navarra,Comunidad Autónoma de Valencia
United Kingdom (Northern Ireland)Northern Ireland
----------------------
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland."(3)in Annex IV, Part II is replaced by the following:"PART IIMember States or zones thereof with an approved eradication programme for EBL
Member StateTerritoryDate of initial approval as referred to in Article 15(2) of Delegated Regulation (EU) 2020/689
CroatiaWhole territory18 July 2022"
(4)in Annex VII, Parts I and II are replaced by the following:"PART IMember States or zones thereof with disease-free status from BVD
Member StateTerritory
AustriaWhole territory
DenmarkWhole territory
FinlandWhole territory
GermanyBundesland Baden-WürttembergBundesland Bayern:The following cities and Landkreis in Regierungsbezirk Oberbayern: Ingolstadt, Stadt München, Stadt Rosenheim, Altötting, Berchtesgadener Land, Bad Tölz-Wolfratshausen, Ebersberg, Eichstätt, Erding, Freising, Fürstenfeldbruck, Garmisch-Partenkirchen, Landsberg am Lech, Miesbach, Mühldorf am Inn, Lkr. München, Neuburg-Schrobenhausen, Pfaffenhofen an der Ilm, Lkr. Rosenheim, Starnberg, Traunstein, Weilheim-SchongauThe following cities and Landkreis in Regierungsbezirk Niederbayern: Stadt Landshut, Stadt Passau, Stadt Straubing, Freyung-Grafenau, Kelheim, Lkr. Landshut, Lkr. Passau, Regen, Rottal-InnThe following cities and Landkreis in Regierungsbezirk Oberpfalz: Stadt Amberg, Stadt Regensburg, Weiden in der Oberpfalz, Lkr. Amberg-Sulzbach, Cham, Neumarkt in der Oberpfalz, Neustadt an der Waldnaab, Lkr. Regensburg, Schwandorf, TirschenreuthThe following cities and Landkreis in Regierungsbezirk Oberfranken: Stadt Bamberg, Stadt Bayreuth, Stadt Coburg, Stadt Hof, Lkr. Bamberg, Lkr. Bayreuth, Lkr. Coburg, Forchheim, Lkr. Hof, Kronach, Kulmbach, Lichtenfels, Wunsiedel im FichtelgebirgeThe following cities and Landkreis in Regierungsbezirk Mittelfranken: Stadt Ansbach, Stadt Erlangen, Stadt Fürth, Nürnberg, Schwabach, Lkr. Ansbach, Lkr. Erlangen-Höchstadt, Lkr. Fürth, Nürnberger Land, Neustadt an der Aisch-Bad Windsheim, Roth, Weißenburg-GunzenhausenThe following cities and Landkreis in Regierungsbezirk Unterfranken: Stadt Aschaffenburg, Stadt Schweinfurt, Stadt Würzburg, Lkr. Aschaffenburg, Bad Kissingen, Röhn-Grabfeld, Haßberge, Kitzingen, Miltenberg, Main-Spessart, Lkr. Schweinfurt, Lkr. WürzburgThe following cities and Landkreis in Regierungsbezirk Schwaben: Stadt Augsburg, Kaufbeuren, Kempten im Allgäu, Memmingen, Aichach-Friedberg, Dillingen an der Donau, Neu-Ulm, Lindau, Oberallgäu, Unterallgäu, Donau-RiesBundesland BrandenburgBundesland BremenBundesland HamburgBundesland HessenBundesland Mecklenburg-VorpommernBundesland Rheinland-PfalzBundesland SaarlandBundesland SachsenBundesland Sachsen-AnhaltBundesland Thüringen
SwedenWhole territory
PART IIMember States or zones thereof with an approved eradication programme for BVD
Member StateTerritoryDate of initial approval as referred to in Article 15(2) of Delegated Regulation (EU) 2020/689
GermanyBundesland Bayern:The following cities and Landkreis in Regierungsbezirk Oberbayern: DachauThe following cities and Landkreis in Regierungsbezirk Niederbayern: Deggendorf, Lkr. Straubing-Bogen, Dingolfing-LandauThe following cities and Landkreis in Regierungsbezirk Schwaben: Lkr. Augsburg, Günzburg, OstallgäuBundesland BerlinBundesland NiedersachsenBundesland Nordrhein-WestfalenBundesland Schleswig-Holstein21 February 2022
IrelandWhole territory18 July 2022"
(5)in Annex VIII, in Part 1, the entry for Germany is replaced by the following:
Member StateTerritory
"GermanyBundesland Baden-WürttembergBundesland BayernBundesland BerlinBundesland BrandenburgBundesland BremenBundesland HamburgBundesland HessenBundesland Mecklenburg-VorpommernBundesland NiedersachsenBundesland Nordrhein-WestfalenBundesland SachsenBundesland Sachsen-AnhaltBundesland Schleswig-HolsteinBundesland Thüringen"